Given a lipid panel with total cholesterol under 200 mg/dL, HDL over 40 mg/dL, LDL under 100 mg/dL, and triglycerides under 150 mg/dL, what is the recommended first-line management?

Given a lipid panel with total cholesterol under 200 mg/dL, HDL over 40 mg/dL, LDL under 100 mg/dL, and triglycerides under 150 mg/dL, what is the recommended first-line management?

• A. Fenofibrate alone
• B. Lifestyle modification then fenofibrate or niacin
• C. Niacin alone
• D. Statin therapy

Answer: (B)

The main idea here is that when the lipid panel shows optimal results—LDL under 100, triglycerides under 150, HDL over 40, and total cholesterol under 200—the best first step is nonpharmacologic management. Lifestyle modifications such as a heart-healthy diet (for example, Mediterranean or DASH), regular aerobic exercise, weight management, and avoidance of tobacco are chosen first because they can further reduce ASCVD risk without drug-related side effects. Pharmacotherapy isn’t indicated immediately since the lipid targets are already met. If targets aren’t maintained after a period of lifestyle changes, or if there are additional risk factors, medication can be considered. In this context, a clinician might think about drugs like fenofibrate or niacin for persistent abnormalities in triglycerides or HDL, but these aren’t the primary move when the lipid numbers are already in the desirable range. The other drug options would not be the best first choice given the current values, since there’s no initial indication to lower LDL further or aggressively modify triglycerides.

The main idea here is that when the lipid panel shows optimal results—LDL under 100, triglycerides under 150, HDL over 40, and total cholesterol under 200—the best first step is nonpharmacologic management. Lifestyle modifications such as a heart-healthy diet (for example, Mediterranean or DASH), regular aerobic exercise, weight management, and avoidance of tobacco are chosen first because they can further reduce ASCVD risk without drug-related side effects. Pharmacotherapy isn’t indicated immediately since the lipid targets are already met.

If targets aren’t maintained after a period of lifestyle changes, or if there are additional risk factors, medication can be considered. In this context, a clinician might think about drugs like fenofibrate or niacin for persistent abnormalities in triglycerides or HDL, but these aren’t the primary move when the lipid numbers are already in the desirable range. The other drug options would not be the best first choice given the current values, since there’s no initial indication to lower LDL further or aggressively modify triglycerides.